Skip to main content


Trump administration drops plan to curb drug rebates

By The Wall Street Journal  
   July 11, 2019

The Trump administration is dropping a plan to curb billions of dollars in annual rebates that drugmakers give middlemen in Medicare, a proposal it had said would drive down the prices consumers pay for prescription drugs.

Full story

Get the latest on healthcare leadership in your inbox.